"Switzerland" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A country in Europe. It is bordered by Austria, France, Italy, Liechtenstein, and Germany. The capital is Bern.
Descriptor ID |
D013557
|
MeSH Number(s) |
Z01.542.883
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Switzerland".
Below are MeSH descriptors whose meaning is more specific than "Switzerland".
This graph shows the total number of publications written about "Switzerland" by people in this website by year, and whether "Switzerland" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2003 | 0 | 2 | 2 |
2005 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2018 | 0 | 2 | 2 |
2020 | 0 | 1 | 1 |
2023 | 0 | 3 | 3 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Switzerland" by people in Profiles.
-
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland. Respiration. 2024; 103(9):593-600.
-
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]. Pneumologie. 2024 Jan; 78(1):35-46.
-
Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studies. Cancer Med. 2023 10; 12(20):20423-20436.
-
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. Hematol Oncol. 2023 Jun; 41 Suppl 2:71-73.
-
Viscoelastic testing in pediatric patients. Transfusion. 2020 10; 60 Suppl 6:S75-S85.
-
Complications Associated with Medical Tourism for Facial Rejuvenation: A Systematic Review. Aesthetic Plast Surg. 2020 06; 44(3):1058-1065.
-
Survey by TEDDY European Network of Excellence for Paediatric Clinical Research demonstrates potential for Europe-wide trials. Acta Paediatr. 2020 03; 109(3):607-612.
-
Ruptured PICA aneurysms: presentation and treatment outcomes compared to other posterior circulation aneurysms. A Swiss SOS study. Acta Neurochir (Wien). 2019 07; 161(7):1325-1334.
-
Ruptured posterior circulation aneurysms: epidemiology, patterns of care, and outcomes from the Swiss SOS national registry. Acta Neurochir (Wien). 2019 04; 161(4):769-779.
-
Risk Factors for Dropping Out of Neurosurgical Residency Programs-A Survey Study. World Neurosurg. 2018 Dec; 120:e100-e106.